Background illustration for clinical trials search

Paid Clinical Trials Brockton

Discover 3,059 paid clinical trials in Brockton, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: Boston MA, Providence RI, Worcester MA, Springfield MA,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 25

Code: NCT03959085

Phase 3, Recruiting

GpCRC Pediatric Gastroparesis Registry 2

for
Gastroparesis, Gastroparesis-like Syndrome
Location: Boston MA, Columbus OH, Milwaukee WI, Houston TX,
Sponsor: Johns Hopkins Bloomberg School of Public Health

Sex: All

Age: 8 - 25

Code: NCT05981300

Recruiting

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

for
Non-Hodgkin Lymphoma, B-cell Acute Lymphoblastic Leukemia,
Location: Boston MA, Providence RI, New York NY, Baltimore MD,
Sponsor: Imugene Limited

Sex: All

Age: 18+

Code: NCT03666000

Phase 1, Recruiting

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

for
Embryonal Rhabdomyosarcoma,
Location: Boston MA, Providence RI, Worcester MA, Hartford CT,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 21

Code: NCT05304585

Phase 3, Recruiting

ATTUNE: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION440 in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome (MDS)

for
Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome
Location: Boston MA, Philadelphia PA, Baltimore MD, Nashville TN,
Sponsor: Ionis Pharmaceuticals, Inc.

Sex: Male

Age: 2 - 65

Code: NCT06430385

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors

for
Low-grade Glioma, Advanced Solid Tumor
Location: Boston MA, New York NY, Philadelphia PA, Montreal,
Sponsor: Day One Biopharmaceuticals, Inc.

Sex: All

Age: 0 - 25

Code: NCT04775485

Phase 2, Recruiting

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

for
Relapsing Multiple Sclerosis, Multiple Sclerosis
Location: Boston MA, Norfolk MA, Burlington MA, Hartford CT,
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06433752

Recruiting

Phase 1 Study of Intratumoral Administration of VAX014 With Expansion in Combination With a Checkpoint Inhibitor in Subjects With Advanced Solid Tumors

for
Advanced Solid Tumor,
Location: Boston MA, Lebanon NH, Morristown NJ,
Sponsor: Vaxiion Therapeutics

Sex: All

Age: 18+

Code: NCT05901285

Phase 1, Recruiting

Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma

for
Neuroblastoma, High-risk Neuroblastoma
Location: Boston MA, Hartford CT, New York NY, Philadelphia PA,
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 0 - 17

Code: NCT06831552

Recruiting

Genetics of Epilepsy and Related Disorders

for
Epilepsy, Epileptic Encephalopathy
Location: Boston MA
Sponsor: Boston Children's Hospital

Sex: All

Age: 0+

Code: NCT01858285

Recruiting

Cardiac Sarcoidosis Randomized Trial

for
Cardiac Sarcoidosis, Sarcoidosis
Location: Boston MA, New Haven CT, New York NY, Sherbrooke,
Sponsor: Ottawa Heart Institute Research Corporation

Sex: All

Age: 18+

Code: NCT03593759

Phase 3, Recruiting

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

for
Ovarian Carcinoma
Location: Boston MA, Providence RI, Waterford CT, Springfield MA,
Sponsor: NRG Oncology

Sex: Female

Age: 35 - 50

Code: NCT04251052

Recruiting

A Study of Participants With Cerebral Adrenoleukodystrophy (CALD) Treated With Elivaldogene Autotemcel

for
Cerebral Adrenoleukodystrophy (CALD)
Location: Boston MA, Philadelphia PA, Dallas TX
Sponsor: bluebird bio

Sex: Male

Age: 0+

Code: NCT06224413

Recruiting

Distal Radius Interventions for Fracture Treatment

for
Fracture Distal Radius
Location: Boston MA, The Bronx NY, New York NY, New Brunswick NJ,
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago

Sex: All

Age: 4 - 10

Code: NCT05131685

Recruiting

Computer Adaptation of Screening, Brief MET Intervention to Reduce Teen Drinking

for
Alcohol Abuse, Tobacco Use Disorder, Substance Use
Location: Boston MA
Sponsor: Boston Children's Hospital

Sex: All

Age: 14 - 20

Code: NCT01881841

Recruiting

College Mental Health Project

for
Depression
Location: Belmont MA
Sponsor: Mclean Hospital

Sex: All

Age: 18 - 25

Code: NCT03345459

Recruiting

Noise-Enhanced Sensory Function in Elders at Risk for Falls

for
Aging, Somatosensory Deficit
Location: Boston MA
Sponsor: National Institute on Aging (NIA)

Sex: All

Age: 70+

Code: NCT00421759

Recruiting

Pompe Disease Registry Protocol

for
Glycogen Storage Disease Type II, Pompe Disease
Location: Boston MA, Springfield MA, New Haven CT, Portland ME,
Sponsor: Genzyme, a Sanofi Company

Sex: All

Age: 0+

Code: NCT00231400

Recruiting

A Study of ASP3082 in Adults With Advanced Solid Tumors

for
Solid Tumor
Location: Boston MA, New Haven CT, New York NY, Hackensack NJ,
Sponsor: Astellas Pharma Inc

Sex: All

Age: 18+

Code: NCT05382559

Phase 1, Recruiting

A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

for
Relapsed or Refractory Multiple Myeloma
Location: Boston MA, Farmington CT, Shirley NY, Lake Success NY,
Sponsor: Celgene

Sex: All

Age: 18+

Code: NCT05519085

Phase 3, Recruiting